Abuse potential and adverse cognitive effects of mitragynine (kratom)

Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users

(2014) Darshan Singh et al.   DRUG AND ALCOHOL DEPENDENCE

The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK–N–SH neuroblastoma cell

(2013) Mohd Fadzly Amar Jamil et al.   JOURNAL OF ETHNOPHARMACOLOGY

Orally Active Opioid Compounds from a Non-Poppy Source

(2013) Robert B. Raffa et al.   JOURNAL OF MEDICINAL CHEMISTRY

Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism

(2013) M. A. de Souza Silva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract

(2013) Anne-Christin Stolt et al.   PSYCHOPHARMACOLOGY

What's conditioned in conditioned place preference?

(2013) Joseph P. Huston et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Lentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activity

(2012) Alinda R. Fernandes et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study

(2012) Kamarudin Ahmad et al.   JOURNAL OF ETHNOPHARMACOLOGY

Identification of Synthetic Cannabinoids in Herbal Incense Blends in the United States

(2012) Barry K. Logan et al.   JOURNAL OF FORENSIC SCIENCES

From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction

(2012) Zurina Hassan et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Herbal Medicines for the Management of Opioid Addiction

(2011) Jeanine Ward et al.   CNS DRUGS

Mitragyna speciosa, A Psychoactive Tree from Southeast Asia with Opioid Activity

(2011) Jessica E. Adkins et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

A Coincidence of Addiction to “Kratom” and Severe Primary Hypothyroidism

(2011) Sergey V. Sheleg et al.   Journal of Addiction Medicine

Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264.7 macrophage cells

(2011) Zulkhurnain Utar et al.   JOURNAL OF ETHNOPHARMACOLOGY

Kratom alkaloids and O-desmethyltramadol in urine of a “Krypton” herbal mixture consumer

(2010) Torsten Arndt et al.   FORENSIC SCIENCE INTERNATIONAL

Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds

(2010) Sebastian Dresen et al.   JOURNAL OF MASS SPECTROMETRY

Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression

(2010) N. Farah Idayu et al.   PHYTOMEDICINE

Legal Highs on the Internet

(2010) Jennifer Hillebrand et al.   SUBSTANCE USE & MISUSE

A Case Report of Inpatient Detoxification after Kratom (Mitragyna speciosa) Dependence

(2010) Laura McWhirter et al.   EUROPEAN ADDICTION RESEARCH

The role of cortical serotonin in anxiety and locomotor activity in Wistar rats.

(2009) M. E. Pum et al.   BEHAVIORAL NEUROSCIENCE

Opioid receptors and legal highs:Salvia divinorumand Kratom

(2009) Kavita M. Babu et al.   CLINICAL TOXICOLOGY

The botanical origin of kratom (Mitragyna speciosa; Rubiaceae) available as abused drugs in the Japanese markets

(2009) Takuro Maruyama et al.   Journal of Natural Medicines

Pharmacological Modulation of Dopaminergic Brain Activity and Its Reflection in Spectral Frequencies of the Rat Electropharmacogram

(2009) Wilfried Dimpfel   NEUROPSYCHOBIOLOGY

Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth)

(2008) Edward W. Boyer et al.   ADDICTION